Follow Us:

News

The printer uses bioinks to create structures infused with living cells.   Students and faculty in East Carolina University’s College of Engineering and Technology had the chance to see and discuss the operation of a 3D bioprinter, technology that could lead to the printing of viable human organs. Dr. Barbara Muller-Borer, chair of the Department...

Read more

CELLINK publishes two new protocols in collaboration with TATAA Biocenter. TATAA Biocenter was founded in 2001 by pioneers in qPCR, and have extensive knowledge and hands-on experience within nucleic acid analysis. We are proud to present our protocols using CELLINK bioinks and TATAA’s qPCR technology. The protocols describe the process of extracting RNA using CELLINK bioink,...

Read more

Printing a spinal cord implant, shown here, restored movement in injured rats. FOR DOCTORS AND medical researchers repairing the human body, a 3D printer has become almost as valuable as an x-ray machine, microscope, or a sharp scalpel. Bioengineers are using 3D printers to make more durable hip and knee joints, prosthetic limbs and, recently,...

Read more

Via Davide Sher, 3D Printing Media Network We spoke with CEO Erik Gatenholm about the company’s recent acquisitions and future goals. CELLINK‘s rise from a bioink startup to a bioprinting market global leader has been lightning fast. In 2015 I did my first interview, with founders Erik Gatenholm (CEO), Hector Martinez Avila (CTO) and Gusten...

Read more

PRESS RELEASE Gothenburg, Sweden December 5th, 2018, 08:30 CET CELLINK and Prellis Biologics Inc. sign partnership to commercialize high-resolution holographic bioprinting technology for micro-printing. The partners will utilize their IP, expertise, and know-how to offer the first system enabling ultra-high resolution bioprinting of microstructures such as vascular networks or capillaries. The technology is an important...

Read more

  PRESS RELEASE Gothenburg, Sweden, December 4th, 2018 CELLINK announces a collaboration with MedImmune to utilize CELLINKs’ 3D-Bioprinting technology for drug discovery Scientists will work side-by-side in MedImmune labs, aiming to speed research and development of new therapies. CELLINK, focused on the development and commercialization of innovative bioprinting technologies, announced today that the company will...

Read more

PRESS RELEASE Gothenburg 2018-11-30 CELLINK has entered into an agreement to acquire the Biodispensing company Dispendix GmbH CELLINK AB (“CELLINK”) has entered into an agreement with the owner of Dispendix GmbH. (“Dispendix”) to acquire all shares in Dispendix for a purchase amount of 5 M €(“Acquisition”). “Our innovative products for non-contact, high throughput dispensing and...

Read more

  Name: Oriana Zoghbi Location: Boston, USA Position: North America Sales Director   Hi Oriana! Please tell us a little bit about yourself. I am originally Venezuelan-Lebanese, and have lived in Saudi Arabia, Switzerland, Germany and the US! I speak 4 languages fluently (English, Spanish, Arabic and French), love to travel, and have a passion for leading ambitious...

Read more

  Name: Hany AbuShall Location: Blacksburg, Virginia Position: Electrical Engineer Hi Hany! Please tell us a little bit about yourself. I am an electrical engineer at CELLINK. I was born and raised in Tripoli (Libya) for twelve years and then moved to and lived in Cairo (Egypt) for 16 years. I had my good share of academic research...

Read more

Subscribe to our updates

To be aware of the latest news in
the bioprinting industry.